Hypoglycaemic and hypolipidaemic effects of emodin and its effect on L-type calcium channels in dyslipidaemic-diabetic rats

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 1, 2009, Pages 29-34

  Zhao, Xiao Yan ^a   Qiao, Guo Fen ^a   Li, Bao Xin ^a   Chai, Li Min ^a   Li, Zhe ^a   Lu, Yan Jie ^a   Yang, Bao Feng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Emodin; Heart; Islets of langerhans; L type calcium channels

Indexed keywords

CALCIUM CHANNEL CAV1.2; CALCIUM CHANNEL L TYPE; CHOLESTEROL; EMODIN; FATTY ACID; GLUCOSE; INSULIN; MALONALDEHYDE; ROSIGLITAZONE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DYSLIPIDEMIA; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; IMMUNOFLUORESCENCE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; CALCIUM CHANNELS, L-TYPE; DIABETES MELLITUS, EXPERIMENTAL; DYSLIPIDEMIAS; EMODIN; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; MALE; MOLECULAR STRUCTURE; RATS; RATS, WISTAR;

EID: 58549104950     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05051.x     Document Type: Article

References (38)

1. Kharitonenkov A, Shiyanova TL, Koester A et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 2005 115 : 1627 35.
2. Gikas A, Sotiropoulos A, Panagiotakos D, Peppas T, Skliros E, Peppas S. Prevalence, and associated risk factors, of self-reported diabetes mellitus in a sample of adult urban population in Greece: MEDICAL Exit Poll Research in Salamis (MEDICAL EXPRESS 2002). BMC Public Health 2004 4 : 2.
3. Wagstaff AJ, Goa KL. Rosiglitazone. A review of its use in the management of type 2 diabetes mellitus. Drugs 2002 62 : 1805 37.
4. Maiti R, Das UK, Ghosh D. Attenuation of hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats by aqueous extract of seed of Tamarindus indica. Biol. Pharm. Bull. 2005 28 : 1172 6.
5. Kameswara Rao B, Renuka Sudarshan P, Rajasekhar MD, Nagaraju N, Appa Rao CH. Antidiabetic activity of Terminalia pallida fruit in alloxan induced diabetic rats. J. Ethnopharmacol. 2003 85 : 169 72.
6. Srinivas G, Anto RJ, Srinivas P, Vidhyalakshmi S, Senan VP, Karunagaran D. Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9. Eur. J. Pharmacol. 2003 473 : 117 25.
7. Zhang XP, Li ZF, Liu XG et al. Effects of emodin and baicalein on rats with severe acute pancreatitis. World J. Gastroenterol. 2005 11 : 2095 100.
8. Parker A, Meyer J, Lewitzky S et al. A gene conferring susceptibility to type 2 diabetes in conjuction with obesity is located on chromosome 18pll. Diabetes 2001 50 : 675 80.
9. 2+ channel activities in pancreatic beta cells of non-insulin-dependent diabetes mellitus GK rats. J. Clin. Invest. 1996 97 : 2417 25.
10. Watkins PJ. Cardiovascular disease, hypertension, and lipids. BMJ 2003 326 : 874 6.
11. Strapans J, Rapp JH, Pan XM, Feingold KR. The effect of oxidized lipids in the diet on serum lipoprotein peroxides in control and diabetic rats. J. Clin. Invest. 1993 92 : 638 43.
12. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat. A model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 2005 52 : 313 20.
13. Reed MJ, Meszaros K, Entes LJ et al. A new rat model of type 2 diabetes: The fat fed, streptozotocin-treated rat. Metabolism 2000 49 : 1390 4.
14. 2+ channels. J. Membr. Biol. 2004 200 : 57 66.
15. 2+ channels and their role in neurotransmitter release. Cell Calcium 1998 24 : 307 23.
16. 2+ channels. J. Clin. Invest. 2004 113 : 1430 9.
17. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2006 291 : H1489 506.
18. i) and L-type calcium current of the single ventricular mytocytes from guinea pig. Yao Xue Xue Bao 2004 39 : 5 8 (in Chinese).
19. Pascoe WS, Jenkins AB, Kusunoki M, Stolein LH. Insulin action and determinants of glycaemia in a rat model of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992 35 : 208 15.
20. Chalkley SM, Hettiarachchi M, Chisholm DJ, Kraegen EW. Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats. Am. J. Physiol. Endocrinol. Metab. 2002 282 : E1231 8.
21. Unger RH, Zhou YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001 50 (Suppl. 1 S118 21.
22. Getty L, Panteleon AE, Mittelman SD, Dea MK, Bergman RN. Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo. J. Clin. Invest. 2000 106 : 421 30.
23. Rader DJ. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am. J. Med. 2007 120 (Suppl S12 18.
24. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Invest. 2002 32 (Suppl. 3 14 23.
25. Nishikawa T, Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid. Redox Signal. 2007 9 : 343 53.
26. Bolzan AD, Bianchi MS. Genotoxicity of STZ. Mutat. Res. 2002 512 : 121 34.
27. Dyntar D, Eppenberger-Eberhardt M, Maedler K et al. Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes 2001 50 : 2105 13.
28. Rayasam GV, Tulasi VK, Davis JA, Bansal VS. Fatty acid receptors as new therapeutic targets for diabetes. Expert Opin. Ther. Targets 2007 11 : 661 71.
29. Wajchenberg BL. Beta-cell failure in diabetes and preservation by clinical treatment. Endocr. Rev. 2007 28 : 187 218.
30. Henquin JC, Ravier MA, Nenquin M, Jonas JC, Gilon P. Hierarchy of the β cell signals controlling insulin secretion. Eur. J. Clin. Invest. 2003 33 : 742 50.
31. 2+ channel activity and insulin secretion by the Rem2 GTPase. J. Biol. Chem. 2005 280 : 41 864 71.
32. Del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes 2002 51 (Suppl. 1 S109 16.
33. Dolphin AC. L-Type calcium channel modulation. Adv. Second Messenger Phosphoprotein Res. 1999 33 : 153 77.
34. 2+ channels: A functional patchwork. Trends Neurosci. 2003 26 : 683 7.
35. 2+ channels. J. Clin. Invest. 2004 113 : 1430 9.
36. 2+ channel null mice. EMBO J. 2003 22 : 3844 54.
37. Finck BN, Han X, Courtois M et al. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content. Proc. Natl Acad. Sci. USA 2003 100 : 1226 31.
38. Bers DM. Cardiac excitation-contraction coupling. Nature 2002 415 : 198 205.